Log In
Print
BCIQ
Print
Print this Print this
 

doxylamine/pyridoxine (Diclectin, Diclegis)

  Manage Alerts
Collapse Summary General Information
Company Duchesnay Inc.
DescriptionDelayed-release tablet containing 10 mg doxylamine and 10 mg pyridoxine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsManage pregnancy-induced nausea and vomiting
Regulatory Designation

Partner

Tzamal Medical Group Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today